Insider Trends: 90-Days of Insider Buying at Quest Diagnostics Interrupted with Share Disposition
04:29 PM EDT, 05/11/2021 (MT Newswires) -- Catherine T Doherty, SVP, Group Exec. Clin. Fran., reported a sale of 8,536 shares in Quest Diagnostics (DGX) on May 07, 2021, for $1,194,724. Following the Form 4 filing with the SEC, Doherty has control over a total of 72,835 shares of the company, with 68,729 shares held directly and 4,106 controlled indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $10.30 million.
During the most recent 90-day period, previous to the date of this filing, there have been 33 insider transactions reported to the SEC for Quest Diagnostics. These transactions came from the activities of 7 separate insiders that resulted in a net acquisition of 94,624 company shares. Relative to the preceding 90-day window of time, there were 6 transactions from 4 insiders that resulted in the net disposition of 13,863 shares.
This level of insider transactions is lower than the peer group average in the 54-company Healthcare Facilities & Services peer group over the last 90-day period. Peer group activity averaged 110.7 transactions per company, and disposition of 3,666 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1022079/000102207921000077/xslF345X03/wf-form4_162076480079936.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.